A Study to Compare the Diagnostic Rate of Positive Synovial Fluid Tropheryma Whipplei PCR Results to Clinical Characteristics and Outcomes of Whipple's Disease

Overview

About this study

The purpose of this study is to determine diagnostic usefulness by comparing the rate of positive synovial fluid T. whipplei PCR tests, with the clinical characteristics and outcomes of patients who have Whipple's disease. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • All with T. whipplei SF PCR tests performed between 01/01/2003 and 04/01/2015 at Mayo Clinic

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Robin Patel, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions